189 related articles for article (PubMed ID: 35552827)
1. Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? The MeTHOS cohort study.
Xynogalos S; Simeonidis D; Papageorgiou G; Pouliakis A; Charalambakis N; Lianos E; Mazlimoglou E; Liatsos AN; Kosmas C; Ziras N
Support Care Cancer; 2022 Aug; 30(8):6973-6984. PubMed ID: 35552827
[TBL] [Abstract][Full Text] [Related]
2. Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study.
Akinosoglou K; Savopoulos C; Pouliakis A; Triantafyllidis C; Markatis E; Golemi F; Liontos A; Vadala C; Papanikolaou IC; Dimakopoulou V; Xarras P; Varela K; Kaiafa G; Mitsianis A; Chatzistamati A; Randou E; Savvanis S; Pavlaki M; Efraimidis G; Samaras V; Papazoglou D; Konstantinidou A; Panagopoulos P; Milionis H; On Behalf Of The Interact Study Group
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458497
[TBL] [Abstract][Full Text] [Related]
3. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
[TBL] [Abstract][Full Text] [Related]
4. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
5. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Otten HM; Rutjes AW
Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736
[TBL] [Abstract][Full Text] [Related]
6. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
[TBL] [Abstract][Full Text] [Related]
7. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.
Hyers TM; Spyropoulos AC;
J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932
[TBL] [Abstract][Full Text] [Related]
8. CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.
Lee AY; Bauersachs R; Janas MS; Jarner MF; Kamphuisen PW; Meyer G; Khorana AA;
BMC Cancer; 2013 Jun; 13():284. PubMed ID: 23764005
[TBL] [Abstract][Full Text] [Related]
9. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Ferrante N; Otten HM; Cuccurullo F; Rutjes AW
Cochrane Database Syst Rev; 2012 Feb; (2):CD008500. PubMed ID: 22336844
[TBL] [Abstract][Full Text] [Related]
10. Weight-adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery.
Tseng EK; Kolesar E; Handa P; Douketis JD; Anvari M; Tiboni M; Crowther MA; Siegal DM
J Thromb Haemost; 2018 Oct; 16(10):2008-2015. PubMed ID: 30099852
[TBL] [Abstract][Full Text] [Related]
11. A Longitudinal Study of Thrombosis and Bleeding Outcomes With Thromboprophylaxis in Pregnant Women at Intermediate and High Risk of VTE.
Schapkaitz E; Libhaber E; Gerber A; Rhemtula H; Zamparini J; Jacobson BF; Büller HR
Clin Appl Thromb Hemost; 2023; 29():10760296231160748. PubMed ID: 36972476
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
[TBL] [Abstract][Full Text] [Related]
13. Perioperative Pharmacological Thromboprophylaxis in Patients With Cancer: A Systematic Review and Meta-analysis.
Guo Q; Huang B; Zhao J; Ma Y; Yuan D; Yang Y; Du X
Ann Surg; 2017 Jun; 265(6):1087-1093. PubMed ID: 27849664
[TBL] [Abstract][Full Text] [Related]
14. Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin.
Karathanos C; Kakkos SK; Georgiadis G; Ioannou C; Vasdekis S; Chatzis D; Latzios P; Giannoukas AD;
Phlebology; 2023 Apr; 38(3):141-149. PubMed ID: 36461172
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial.
Auer RC; Ott M; Karanicolas P; Brackstone MR; Ashamalla S; Weaver J; Tagalakis V; Boutros M; Stotland P; Marulanda AC; Moloo H; Jayaraman S; Patel S; Le Gal G; Spadafora S; MacLellan S; Trottier D; Jonker D; Asmis T; Mallick R; Pecarskie A; Ramsay T; Carrier M;
BMJ; 2022 Sep; 378():e071375. PubMed ID: 36100263
[TBL] [Abstract][Full Text] [Related]
16. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.
Christopoulou A; Ardavanis A; Papandreou C; Koumakis G; Papatsimpas G; Papakotoulas P; Tsoukalas N; Andreadis C; Samelis G; Papakostas P; Aravantinos G; Ziras N; Souggleri M; Kalofonos C; Samantas E; Makrantonakis P; Pentheroudakis G; Athanasiadis A; Stergiou H; Bokas A; Grivas A; Tripodaki ES; Varthalitis I; Timotheadou E; Boukovinas I
Oncol Lett; 2022 Apr; 23(4):115. PubMed ID: 35251346
[TBL] [Abstract][Full Text] [Related]
18. Tinzaparin for venous thromboembolism in patients with renal impairment: a single-centre, prospective pilot study.
Yeung J; Dix CHK; Ritchie AG; Kow M; Chen VMY
Intern Med J; 2023 Jan; 53(1):68-73. PubMed ID: 32786035
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy.
Ní Ainle F; Wong A; Appleby N; Byrne B; Regan C; Hassan T; Milner M; Sullivan AO; White B; O'Donnell J
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):689-92. PubMed ID: 18832911
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study.
Klamroth R; Sinn M; Pollich C; Bischoff S; Lohneis A; Orlovic AM; Wisłocka L; Habbel P; de Wit M; Späth-Schwalbe E; Scholz CW; Riess H
Oncol Res Treat; 2022; 45(4):178-185. PubMed ID: 34963120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
